Avantor (NYSE:AVTR) Stock Rating Upgraded by Wall Street Zen

Avantor (NYSE:AVTR – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Sunday, Wall Street Zen reports.

A number of other brokerages have also weighed in on AVTR. Wolfe Research upgraded Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, July 30th. TD Cowen reiterated a “hold” rating on shares of Avantor in a research report on Wednesday, July 15th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $13.00 price objective on shares of Avantor in a report on Thursday, July 30th. Sanford C. Bernstein began coverage on shares of Avantor in a research report on Friday, June 26th. They issued a “market perform” rating and a $10.50 price objective on the stock. Finally, Evercore set a $10.50 target price on shares of Avantor in a research note on Monday, July 6th. Two analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Avantor presently has a consensus rating of “Hold” and a consensus price target of $12.88.

Get Our Latest Stock Report on Avantor

Avantor Stock Down 1.0%

Shares of NYSE:AVTR opened at $15.52 on Friday. The firm has a fifty day moving average price of $14.71 and a two-hundred day moving average price of $11.19. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.78 and a quick ratio of 1.18. Avantor has a one year low of $7.26 and a one year high of $16.38. The company has a market cap of $10.50 billion, a price-to-earnings ratio of -18.48, a PEG ratio of 11.83 and a beta of 0.94.

Avantor (NYSE:AVTR – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.02. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.61 billion. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The business’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the previous year, the business earned $0.24 EPS. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Analysts anticipate that Avantor will post 0.81 EPS for the current fiscal year.

Institutional Investors Weigh In On Avantor

Several hedge funds have recently added to or reduced their stakes in AVTR. Elevation Wealth Partners LLC boosted its position in Avantor by 72.3% during the 3rd quarter. Elevation Wealth Partners LLC now owns 2,803 shares of the company’s stock valued at $42,000 after acquiring an additional 1,176 shares in the last quarter. SJS Investment Consulting Inc. boosted its position in shares of Avantor by 1,599.7% during the first quarter. SJS Investment Consulting Inc. now owns 5,235 shares of the company’s stock valued at $41,000 after purchasing an additional 4,927 shares in the last quarter. IFP Advisors Inc grew its stake in Avantor by 901.4% in the second quarter. IFP Advisors Inc now owns 5,858 shares of the company’s stock worth $58,000 after purchasing an additional 5,273 shares during the period. State of Wyoming purchased a new stake in Avantor in the second quarter worth $74,000. Finally, Parallel Advisors LLC raised its holdings in Avantor by 21.4% in the first quarter. Parallel Advisors LLC now owns 8,452 shares of the company’s stock worth $66,000 after purchasing an additional 1,491 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Avantor Company Profile

(Get Free Report)

Avantor, Inc is a global provider of products, services and solutions used in the life sciences and advanced technology industries. The company supplies materials and equipment that support research, drug discovery and development, biopharmaceutical manufacturing, clinical and diagnostic activities, and other laboratory applications.

Its offerings include laboratory chemicals and reagents, consumables, single-use manufacturing technologies, bioprocessing products, equipment, and related services.

Further Reading

Analyst Recommendations for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.